Board Member at Synlogic, Inc.
Mike has more than 25 years of pharmaceutical development experience, and has focused on clinical-stage product companies, particularly in the oncology and neurology areas. He joined Sofinnova Ventures as a General Partner in 1997. Prior to becoming a venture capitalist, Mike worked on 20 clinical products and authored almost 100 papers and books, including an 1,000-page treatise on vaccine design. Mike was the initial investor in: Actelion (SWX: ATLN), InterMune (Nasdaq: ITMN), Anesiva (Nasdaq: ANSV), Orexigen Therapeutics (Nasdaq: OREX), Seattle Genetics (Nasdaq: SGEN), Threshold Pharmaceuticals (Nasdaq: THLD), and Trius Therapeutics (Nasda ...
Source: Dauntless Pharmaceuticals, Inc. on 04/27/2016
By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Michael F. Powell Ph.D.. More specifically, you'll be able to:
Access over 200,000 executive and board member profiles.
Example: Michael F. Powell Ph.D.
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.